Published in J Am Soc Nephrol on January 21, 2009
Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol (2010) 1.13
The role of complement in tumor growth. Adv Exp Med Biol (2014) 1.11
C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol (2012) 1.05
Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol (2014) 0.97
Complement regulation of T cell immunity. Immunol Res (2012) 0.95
Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol (2015) 0.91
Nitro-oleic acid protects against adriamycin-induced nephropathy in mice. Am J Physiol Renal Physiol (2013) 0.90
Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. Am J Transplant (2011) 0.90
Complement as a multifaceted modulator of kidney transplant injury. J Clin Invest (2014) 0.89
Glomerular proteinuria: a complex interplay between unique players. Adv Chronic Kidney Dis (2011) 0.89
Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians. Clin Exp Immunol (2009) 0.84
Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis. PLoS One (2011) 0.84
Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis. FASEB J (2014) 0.83
The role of the complement system in acute kidney injury. Semin Nephrol (2013) 0.83
Review: Complement and its regulatory proteins in kidney diseases. Nephrology (Carlton) (2010) 0.82
A complement receptor C5a antagonist regulates epithelial to mesenchymal transition and crystallin expression after lens cataract surgery in mice. Mol Vis (2011) 0.82
An update on the pathomechanisms and future therapies of Alport syndrome. Pediatr Nephrol (2012) 0.82
Complement regulation of T-cell alloimmunity. Semin Nephrol (2013) 0.81
Control of the collective migration of enteric neural crest cells by the Complement anaphylatoxin C3a and N-cadherin. Dev Biol (2016) 0.80
Renal fibrosis. Hippokratia (2009) 0.80
Obstacles in haemocompatibility testing. Scientifica (Cairo) (2013) 0.79
Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia. Oncotarget (2014) 0.79
C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway. PLoS One (2014) 0.79
Effects of complement activation on allograft injury. Curr Opin Organ Transplant (2015) 0.79
Proteinuria and epithelial-to-mesenchymal transition: the role of complement. J Am Soc Nephrol (2009) 0.78
Complement regulation of T-cell alloimmunity. Curr Opin Organ Transplant (2011) 0.78
Correlation analysis connects cancer subtypes. PLoS One (2013) 0.77
Complement activation in progressive renal disease. World J Nephrol (2015) 0.77
Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis. FASEB J (2016) 0.76
Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy. Acta Pharmacol Sin (2015) 0.76
The Expression Profile of Complement Components in Podocytes. Int J Mol Sci (2016) 0.75
Targeting the complement cascade: novel treatments coming down the pike. Kidney Int (2016) 0.75
Therapeutic regulation of complement in patients with renal disease - where is the promise? Clin Nephrol (2012) 0.75
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell (2017) 0.75
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest (2002) 12.22
Complement. First of two parts. N Engl J Med (2001) 11.16
BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med (2003) 7.91
Complement. Second of two parts. N Engl J Med (2001) 6.32
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol (2005) 5.88
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol (2007) 5.24
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol (2001) 4.39
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest (2006) 3.41
Transforming growth factor production by chemically transformed cells. Cancer Res (1981) 3.36
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24
Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology (2007) 2.21
Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. J Lab Clin Med (1997) 1.95
Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol (1989) 1.90
Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int Suppl (2004) 1.58
Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol (1987) 1.51
C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J Immunol (2007) 1.45
Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol (1989) 1.44
Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int (2004) 1.36
Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol (2001) 1.36
Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol (1997) 1.28
Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant (1994) 1.18
Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol (1999) 1.18
Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol Dial Transplant (2007) 1.14
Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol (2006) 1.12
Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J (2007) 1.11
Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol (1997) 1.10
Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J Immunol (2005) 1.08
The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. Am J Physiol Renal Physiol (2007) 1.08
Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol (2000) 1.05
C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol (2002) 1.05
Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol (2008) 1.04
Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation (2007) 1.02
The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol (1992) 1.02
Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol (2005) 1.01
Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease. Kidney Int (2003) 0.98
A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol (1991) 0.97
The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J Am Soc Nephrol (1997) 0.95
Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol (2004) 0.95
Role of CD8(+) cells in the progression of murine adriamycin nephropathy. Kidney Int (2001) 0.95
C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin Exp Immunol (2002) 0.94
Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int (1991) 0.92
Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int (1991) 0.90
C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. Kidney Int (1999) 0.89
The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol (2004) 0.89
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int (2004) 0.86
Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in tubular epithelial cells of human, murine and rat kidneys. Immunobiology (2006) 0.86
Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies. Nephron (1997) 0.86
The brush border of proximal tubules of normal human kidney activates the alternative pathway of the complement system in vitro. Ann N Y Acad Sci (1983) 0.83
Complement 3 is involved in changing the phenotype of human glomerular mesangial cells. J Cell Physiol (2007) 0.82
The transcription factors AP-1 and Ets are regulators of C3a receptor expression. J Biol Chem (2005) 0.80
High levels of complement C3a receptor in the glomeruli in lupus nephritis. Am J Kidney Dis (2007) 0.79
Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant (2007) 4.99
CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature (2009) 4.03
Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med (2002) 3.39
The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A (2002) 2.24
Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med (2005) 2.23
Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med (2002) 2.17
The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity (2008) 2.13
Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest (2004) 2.10
Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology (2008) 1.98
Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med (2006) 1.97
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest (2008) 1.94
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med (2003) 1.92
Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol (2004) 1.92
An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem (2005) 1.89
Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol (2006) 1.87
Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol (2004) 1.85
Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int (2010) 1.83
CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol (2007) 1.83
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol (2003) 1.74
The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem (2009) 1.73
Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J Neurosci (2004) 1.65
CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol (2008) 1.61
Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. J Immunol (2006) 1.59
Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol (2006) 1.57
Paranoid psychosis and myoclonus: flecainide toxicity in renal failure. Cardiology (2008) 1.48
Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol (2003) 1.46
Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury. J Clin Invest (2016) 1.43
Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol (2008) 1.42
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am J Pathol (2007) 1.38
Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J (2006) 1.38
C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol (2013) 1.38
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci (2009) 1.37
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood (2007) 1.37
Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood (2008) 1.33
CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med (2012) 1.28
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. Br J Clin Pharmacol (2012) 1.28
Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol (2007) 1.27
Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol (2010) 1.24
Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol (2009) 1.24
Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol (2004) 1.24
Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol (2011) 1.24
Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation (2008) 1.22
The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets (2009) 1.22
Substance P signaling mediates BMP-dependent heterotopic ossification. J Cell Biochem (2011) 1.21
CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection. Eur J Immunol (2005) 1.20
IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol (2006) 1.19
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood (2005) 1.19
Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol (2008) 1.17
Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J Immunol (2002) 1.15
Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res (2002) 1.14
The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy. Exp Diabetes Res (2010) 1.13
3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation. Mol Cell Biol (2006) 1.13
Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J Neurosci (2004) 1.13
Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J Neuroimmunol (2005) 1.12
TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol (2006) 1.12
Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J (2007) 1.11
Attenuation of acute lung inflammation induced by cigarette smoke in CXCR3 knockout mice. Respir Res (2008) 1.10
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J Am Soc Nephrol (2008) 1.08
Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J (2011) 1.08
Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. J Am Soc Nephrol (2006) 1.08
MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2002) 1.08
Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS. Mol Immunol (2011) 1.06
CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp Lung Res (2008) 1.06
Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol (2006) 1.06
Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice. J Immunol (2005) 1.06
CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. Invest Ophthalmol Vis Sci (2005) 1.06
Substance P modulates colitis-associated fibrosis. Am J Pathol (2010) 1.05
C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol (2012) 1.05
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
Impaired lung dendritic cell activation in CCR2 knockout mice. Am J Pathol (2004) 1.04
An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol (2008) 1.04
Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract (2008) 1.03
The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J Clin Invest (2004) 1.03
Mechanisms of disease: the complement system in renal injury--new ways of looking at an old foe. Nat Clin Pract Nephrol (2007) 1.03
CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung. Infect Immun (2005) 1.01
The use of eculizumab in renal transplantation. Clin Transplant (2013) 1.00
The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol (2007) 1.00
Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis. Proc Natl Acad Sci U S A (2012) 1.00
Chemokine receptor CXCR3 promotes growth of glioma. Carcinogenesis (2010) 0.99
The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice. J Immunol (2007) 0.99
Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo. J Neurosci Res (2006) 0.98
CD59a deficiency exacerbates ischemia-reperfusion injury in mice. Am J Pathol (2004) 0.98
Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth. Prostate (2006) 0.98
Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology (2011) 0.97
Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol (2003) 0.97
Illness trajectories: an important concept in the management of kidney failure. Nephrol Dial Transplant (2008) 0.97
Expression of complement components, receptors and regulators by human dendritic cells. Mol Immunol (2011) 0.96
Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J Immunol (2011) 0.96
Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation. Physiol Genomics (2003) 0.95
Retracted Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. Circ Res (2008) 0.95